I wouldn’t heed much from what she said. I find it extremely unlikely that Bell Potter would know of the Interim Analysis results before the US/NIH would do their press release. She stated that MSB had a ‘vaccine’ candidate and confused the 75% off vents in 10 days from the EAP with the Interim analysis n=90. Given that most COVID-19 interventions have lacked robust scientific rigour - I doubt anyone would want this rushed. The independent DSMB have probably only just been unblinded to the results.
Of course, I hope I’m wrong and there is a leak and we’re all millionaires LOL!
Cell Therapy News/Articles, page-5696
-
- There are more pages in this discussion • 12,550 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |